Microorganisms (Aug 2024)

Enhancing Antibiotic Efficacy and Combating Biofilm Formation: Evaluating the Synergistic Potential of <i>Origanum vulgare</i> Essential Oil against Multidrug-Resistant Gram-Negative Bacteria

  • Bilal Saoudi,
  • Karim Bariz,
  • Sarah Saci,
  • Yousra Belounis,
  • Hakima Ait Issad,
  • Mohamed Abbaci,
  • Mohamed Abou Mustapha,
  • El-Hafid Nabti,
  • Rawaf Alenazy,
  • Mohammed Sanad Alhussaini,
  • Abdulrahman A. I. Alyahya,
  • Mohammed Alqasmi,
  • Maryam S. Alhumaidi,
  • Fawaz M. Almufarriji,
  • Karim Houali

DOI
https://doi.org/10.3390/microorganisms12081651
Journal volume & issue
Vol. 12, no. 8
p. 1651

Abstract

Read online

Multidrug-resistant (MDR) Gram-negative bacteria remain a global public health issue due to the barrier imposed by their outer membrane and their propensity to form biofilms. It is becoming imperative to develop new antibacterial strategies. In this context, this study aims to evaluate the antibacterial efficacy of Origanum vulgare essential oil (OEO), alone and in combination with antibiotics, as well as its antibiofilm action against multidrug-resistant Gram-negative strains. OEO components were identified by gas chromatography-mass spectrometry (GC-MS), and antibacterial activity was assessed using the agar diffusion test and the microdilution method. Interactions between OEO and antibiotics were examined using the checkerboard method, while antibiofilm activity was analyzed using the crystal violet assay. Chemical analysis revealed that carvacrol was the major compound in OEO (61.51%). This essential oil demonstrated activity against all the tested strains, with inhibition zone diameters (IZDs) reaching 32.3 ± 1.5 mm. The combination of OEO with different antibiotics produced synergistic and additive effects, leading to a reduction of up to 98.44% in minimum inhibitory concentrations (MICs). In addition, this essential oil demonstrated an ability to inhibit and even eradicate biofilm formation. These results suggest that OEO could be exploited in the development of new molecules, combining its metabolites with antibiotics.

Keywords